About Spect
Spect is a company based in San Francisco (United States) founded in 2017 by Rishab Gargeya and Theodore Leng. It operates as a HealthTech and Product-as-a-Service. Spect has raised $1.68 million across 4 funding rounds from investors including MedTech Innovator and Y Combinator. Spect offers products and services including Spect Retinal Camera and Spect Telemedicine Platform. Spect operates in a competitive market with competitors including Smartlens, Okko Health, Myopia, Color Blind Check and Visual Acuity, among others.
- Headquarter San Francisco, United States
- Founders Rishab Gargeya, Theodore Leng
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spect Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.68 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
MedTech Innovator
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spect
Spect offers a comprehensive portfolio of products and services, including Spect Retinal Camera and Spect Telemedicine Platform.
Portable camera used for retinal eye exams anywhere.
Platform for transferring and displaying retinal exam data.
People of Spect
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Spect
Spect has successfully raised a total of $1.68M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spect
Spect has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include MedTech Innovator and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Spect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spect
Investment portfolio details for Spect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spect
Detailed financials for Spect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spect Comparisons
Peer comparison for Spect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spect
Spect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Smartlens, Okko Health, Myopia, Color Blind Check and Visual Acuity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive devices for eye pressure measurement are provided by Smartlens.
|
|
| Locked | Locked | Locked |
Eye health is monitored at home using a specialized app.
|
|
| Locked | Locked | Locked |
Myopia prevention app monitors family screen habits and distances.
|
|
| Locked | Locked | Locked |
Offers a mobile app to check for color blindness.
|
|
| Locked | Locked | Locked |
Delivers software solutions for visual care and diagnostics.
|
Detailed competitors of Spect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spect
Complete news archive for Spect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spect
Spect was founded in 2017.
Spect is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Rishab Gargeya is the current CEO of Spect. They have also founded this company.
Spect is a funded company, having raised a total of $1.68M across 4 funding rounds to date.
Spect is engaged in providing innovative solutions to prevent blindness by enabling early detection of eye diseases. The company offers a portable retinal camera and a telemedicine platform to conduct retinal exams anywhere, addressing critical healthcare gaps. Services are deployed across various sectors including primary care, community health centers, and at-home care in the United States. Their solutions facilitate quick exams, seamless integration into clinical workflows, and ensure data privacy with compliance to FDA, SOC 2, and HIPAA standards.
Spect's top competitors include Okko Health, Myopia and Smartlens.
Spect offers Spect Retinal Camera and Spect Telemedicine Platform.
Spect has 2 investors. Key investors include MedTech Innovator, and Y Combinator.